Publications

Probity Medical Research has compiled journals, articles and presentations for your personal review. Please use the search features below to find an article.

 

If you would like to request an article for personal review please complete the registration form. These publications are for personal use only and cannot be distributed. 

Register

 

Already granted access to an article?  

Login

 

If you cannot find the article you are looking for please contact Probity Medical Research. 

Journals, Articles and Presentations

Found 32 matches.
Page:
1
Refine your search to narrow the results.

Rapid Onset of Action in Patients With Moderate-to-Severe Psoriasis Treated With Brodalumab: A Pooled Analysis of Data from Two Phase 3 Randomized Clinical Trials (AMAGINE-2 and AMAGINE-3)

2017 Aug;77(2):372-374.

Journal
Journal of the American Academy of Dermatology
PubMed ID
28711089
Condition
Psoriasis
Author
Andrew Blauvelt, Kim A. Papp, Mark G. Lebwohl, Lawrence J. Green, Sylvia Hsu, Varsha Bhatt, Shipra Rastogi, Radhakrishnan Pillai, Robert Israel
Year
2017
Register & Request Access

Distribution of Improvements in Psoriasis Area and Severity Index from the Phase 2 Trial of Risankizumab in Moderate to Severe Plaque Psoriasis

36th Fall Clinical Dermatology Conference, Las Vegas, Nevada, USA, Nov 2017
18th Las Vegas Dermatology Seminar, Las Vegas, Nevada, USA, Nov 2017.

Condition
Psoriasis
Author
Bruce Strober, Kim A Papp, Mary Flack, Yihua Gu, Elizabeth H Z Thompson, Wendell C Valdecantos
Year
2017
Register & Request Access

Clinical Responses in Patients with Moderate-to-Severe Plaque Psoriasis Following Withdrawal and Re-treatment with Risankizumab or Switching from Ustekinumab to Risankizumab

36th Fall Clinical Dermatology Conference, Las Vegas, Nevada, USA, Nov 2017.
18th Las Vegas Dermatology Seminar, Las Vegas, Nevada, USA, Nov 2017.

Condition
Psoriasis
Author
Kim A Papp, Andrew Blauvelt, Mary Flack, Yihua Gu, Elizabeth H Z Thompson
Year
2017
Register & Request Access

Optimising rosacea care: goal setting and using combination treatments

26th EADV Congress, Geneva, Switzerland, Sep 2017.

Condition
Rosacea
Author
J. Del Rosso, K. Papp, M. Gooderham, M. Schaller, J. Tan, G. Schäfer, E. Tanghetti
Year
2017
Register & Request Access

Low Rates of Major Adverse Cardiac Events, Malignancies, and Serious Infections in Subjects with Psoriasis and Psoriatic Arthritis Treated With Apremilast for 156 Weeks: Pooled Analysis From the ESTEEM and PALACE 1-3 Phase 3 Trials

ACR/ARHO Annual Meeting, San Diego, California, USA, Nov 2017.

Condition
Psoriatic Arthritis
Author
Arthur Kavanaugh, Matthias Augustin, Eric Lespessailles, Kim A. Papp, Maria Paris, Rongdean Chen, Dafna D. Gladman, David M. Pariser, Ketty Peris
Year
2017
Register & Request Access

Integrated efficacy analysis of tofacitinib, an oral Janus kinase inhibitor, in patients with active psoriatic arthritis

Presented at the Annual European Congress of Rheumatology, Madrid, Spain, Jun 2017.

Condition
Psoriatic Arthritis
Author
P Nash, LC Coates, R Fleischmann, KA Papp, JJ Gomez-Reino, K Kanik, C Wang, J Wu, T Hendrikx, WC Ports
Year
2017
Register & Request Access

Rapid onset of efficacy in patients with psoriasis treated with brodalumab versus ustekinumab: A pooled analysis of data from two phase 3 randomized clinical trials (AMAGINE-2 and AMAGINE-3)

Annual Meeting of the American Academy of Dermatology, Orlando, Florida, USA, Mar 2017.

Condition
Psoriasis
Author
Kim A Papp, Mark G Lebwohl, Varsha Bhatt, Shipra Rastogi, Radhakrishnan Pillai, Robert J Israel
Year
2017
Register & Request Access

Impact of previous biologic use and failure on efficacy of brodalumab and ustekinumab: A pooled analysis of data from two phase 3 randomized clinical trials in moderate-to-severe plaque psoriasis (AMAGINE-2 and AMAGINE-3)

Annual Meeting of the American Academy of Dermatology, Orlando, Florida, USA, Mar 2017.

Condition
Psoriasis
Author
Kim A Papp, Mark G Lebwohl, James G Krueger, Alice B Gottlieb, Shipra Rastogi, Radhakrishnan Pillai, Robert J Israel
Year
2017
Register & Request Access

Adverse Events of Interest in Patients With Psoriasis and Psoriatic Arthritis: Pooled Analysis From Apremilast Phase 3 Trials

Presented at 45th Congress of the German Society of Rheumatology, Stuttgart, Germany, Sep 2017.

Condition
Psoriasis and Psoriatic Arthritis
Author
Arthur Kavanaugh, Matthias Augustin, Eric Lespessailles, Kim A. Papp, Maria Paris, Rongdean Chen, Dafna D. Gladman, David M. Pariser, Georg Schett, Ketty Peris
Year
2017
Register & Request Access

Patients with psoriasis have different preferences for topical therapy, highlighting the importance of individualized treatment approaches: randomized phase IIIb PSO-INSIGHTFUL study

2017 Nov;31(33):1876-1883

Journal
Journal of the European Academy of Dermatology and Venerology
PubMed ID
28796913
Condition
Psoriasis
Author
C-H. Hong, K.A. Papp, K.W. Lophaven, P. Skallerup, S. Philipp
Year
2017
Register & Request Access
Page:
1

Copyright 2014 Probity Medical Research Inc. All Rights Reserved.

Login